Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP993143.RA7krWHnk6Kn13tMACfrZsnlSRCIRQYTHfsPytjEJYwxU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP993143.RA7krWHnk6Kn13tMACfrZsnlSRCIRQYTHfsPytjEJYwxU130_assertion type Assertion NP993143.RA7krWHnk6Kn13tMACfrZsnlSRCIRQYTHfsPytjEJYwxU130_head.
- NP993143.RA7krWHnk6Kn13tMACfrZsnlSRCIRQYTHfsPytjEJYwxU130_assertion description "[The frequency of miR-126 downregulation was 100.0% in FAP adenomas, 85.7% in FAP intramucosal carcinomas, 78.9% in invasive carcinomas, 81.3% in Lynch syndrome tumors, 68.4% in MSS tumors, and 65.4% in MSI-H tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993143.RA7krWHnk6Kn13tMACfrZsnlSRCIRQYTHfsPytjEJYwxU130_provenance.
- NP993143.RA7krWHnk6Kn13tMACfrZsnlSRCIRQYTHfsPytjEJYwxU130_assertion evidence source_evidence_literature NP993143.RA7krWHnk6Kn13tMACfrZsnlSRCIRQYTHfsPytjEJYwxU130_provenance.
- NP993143.RA7krWHnk6Kn13tMACfrZsnlSRCIRQYTHfsPytjEJYwxU130_assertion SIO_000772 24994098 NP993143.RA7krWHnk6Kn13tMACfrZsnlSRCIRQYTHfsPytjEJYwxU130_provenance.
- NP993143.RA7krWHnk6Kn13tMACfrZsnlSRCIRQYTHfsPytjEJYwxU130_assertion wasDerivedFrom befree-20150227 NP993143.RA7krWHnk6Kn13tMACfrZsnlSRCIRQYTHfsPytjEJYwxU130_provenance.
- NP993143.RA7krWHnk6Kn13tMACfrZsnlSRCIRQYTHfsPytjEJYwxU130_assertion wasGeneratedBy ECO_0000203 NP993143.RA7krWHnk6Kn13tMACfrZsnlSRCIRQYTHfsPytjEJYwxU130_provenance.